Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Aug 18, 2022
Date Accepted: Apr 30, 2023

The final, peer-reviewed published version of this preprint can be found here:

Assessment of Frailty by the French Version of the Vulnerable Elders Survey-13 on Digital Tablet: Validation Study

Zolnowski-Kolp V, Um Din N, Havreng-Théry C, Pariel S, Veyron JH, Lafuente-Lafuente C, Belmin J

Assessment of Frailty by the French Version of the Vulnerable Elders Survey-13 on Digital Tablet: Validation Study

J Med Internet Res 2023;25:e42017

DOI: 10.2196/42017

PMID: 37531175

PMCID: 10433029

Assessment of frailty by the French version of the Vulnerable Elders Survey-13 on digital tablet: a validation study.

  • Victoria Zolnowski-Kolp; 
  • Nathavy Um Din; 
  • Charlotte Havreng-Théry; 
  • Sylvie Pariel; 
  • Jacques-Henri Veyron; 
  • Carmelo Lafuente-Lafuente; 
  • Joel Belmin

ABSTRACT

Background:

The assessment of frailty is a major issue in geriatric medicine. The Vulnerable Elders Survey-13 (VES-13) is a simple and practical tool that identifies frailty through a 13-item questionnaire completed by older adults or their family caregivers by self-administration (pencil and paper) or by telephone interview. The VES-13 provides a 10-point score that is also a recognized predictor of mortality.

Objective:

To design an electronic version of the Echelle de Vulnérabilité des Ainés-13, the French version of the VES-13 - (eEVA-13) for use on a digital tablet and validate it.

Methods:

The scale was implemented as a webApp in three different screens and used on an Android tablet (14.0 x 25.6 cm). Participants were patients attending the outpatient clinic of a French geriatric hospital or hospitalized in a rehabilitation ward and family caregivers of geriatric patients. They completed the scale twice, once by a reference method (self-administered questionnaire or telephone interview) and once by eEVA-13 using the digital tablet. Agreement for diagnosis of frailty was assessed by the kappa coefficient, and scores were compared by Bland and Altman plots and interclass correlation coefficients (ICC). User experience was assessed by a self-administered questionnaire.

Results:

Eighty-six participants, including 40 patients and 46 family caregivers, participated in the study. The agreement between the eEVA-13 and the reference method for the diagnosis of frailty was excellent (kappa 0.92). Bland and Altman plots showed a high level of agreement between the eEVA-13 and the reference methods and ICC value was 0.997 (95% CI: 0.994-0.998) for the paper and tablet group and 0.977 (95% CI: 0.957-0.988) for the phone and tablet group.

Conclusions:

The eEVA-13 is an appropriate digital tool for diagnosing frailty and can be used by older adults and their family caregivers. The scores obtained with eEVA-13 are highly correlated with those obtained with the original version. Clinical Trial: Research project n° 20.08.04.58402 RIPH3 HPS, N° ID RCB : 2020-A02331-38


 Citation

Please cite as:

Zolnowski-Kolp V, Um Din N, Havreng-Théry C, Pariel S, Veyron JH, Lafuente-Lafuente C, Belmin J

Assessment of Frailty by the French Version of the Vulnerable Elders Survey-13 on Digital Tablet: Validation Study

J Med Internet Res 2023;25:e42017

DOI: 10.2196/42017

PMID: 37531175

PMCID: 10433029

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.